29 related articles for article (PubMed ID: 15127232)
1. Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients.
Minami H; Kawada K; Sasaki Y; Igarashi T; Saeki T; Tahara M; Itoh K; Fujii H
Cancer Sci; 2006 Mar; 97(3):235-41. PubMed ID: 16542221
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.
Slaviero KA; Clarke SJ; McLachlan AJ; Blair EY; Rivory LP
Br J Clin Pharmacol; 2004 Jan; 57(1):44-53. PubMed ID: 14678339
[TBL] [Abstract][Full Text] [Related]
3. Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort.
de Vries Schultink AHM; Crombag MBS; van Werkhoven E; Otten HM; Bergman AM; Schellens JHM; Huitema ADR; Beijnen JH
Cancer Med; 2019 Apr; 8(4):1406-1415. PubMed ID: 30802002
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials.
Yano R; Konno A; Watanabe K; Tsukamoto H; Kayano Y; Ohnaka H; Goto N; Nakamura T; Masada M
Int J Clin Oncol; 2013 Feb; 18(1):96-104. PubMed ID: 22095245
[TBL] [Abstract][Full Text] [Related]
5. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M
J Clin Oncol; 2006 Aug; 24(22):3657-63. PubMed ID: 16877734
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of oral topotecan in advanced non-small cell lung cancer.
White SC; Cheeseman S; Thatcher N; Anderson H; Carrington B; Hearn S; Ross G; Ranson M
Clin Cancer Res; 2000 Mar; 6(3):868-73. PubMed ID: 10741709
[TBL] [Abstract][Full Text] [Related]
7. Second-line chemotherapy with a modified schedule of docetaxel in elderly patients with advanced-stage non-small-cell lung cancer.
Tibaldi C; Bernardini I; Chella A; Russo F; Vasile E; Malventi M; Falcone A
Clin Lung Cancer; 2006 May; 7(6):401-5. PubMed ID: 16800966
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer.
Kim HJ; Kim TG; Lee HJ; Kim JH; Lim BH; Seo JW; Kang EM; Lee BU; Ahn YM; Roh YH; Nam SH; Kim BS
Lung Cancer; 2010 May; 68(2):248-52. PubMed ID: 19647333
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
Nugent FW; Mertens WC; Graziano S; Levitan N; Collea R; Gajra A; Marshall J; McCann J
Lung Cancer; 2005 May; 48(2):267-73. PubMed ID: 15829328
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
Takigawa N; Segawa Y; Kishino D; Fujiwara K; Tokuda Y; Seki N; Shinkai T; Watanabe Y; Hiraki S; Kozuki T; Gemba K; Tabata M; Kiura K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2004 Sep; 54(3):230-6. PubMed ID: 15127232
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel administration schedule: from fever to tears? A review of randomised studies.
Engels FK; Verweij J
Eur J Cancer; 2005 May; 41(8):1117-26. PubMed ID: 15911234
[TBL] [Abstract][Full Text] [Related]
12. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.
Engels FK; Sparreboom A; Mathot RA; Verweij J
Br J Cancer; 2005 Jul; 93(2):173-7. PubMed ID: 16012521
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
